Sanofi has partnered with U.K.-based Healx to leverage AI in identifying new rare disease indications for a discontinued drug asset. Healx will utilize its AI-driven platform, Healnet, to analyze data provided by Sanofi, aiming to support the compound's future development. This collaboration underscores both companies' commitment to innovative therapies for patients with limited treatment options.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
